A Study With Clevudine Monotherapy or Adefovir and Clevudine Combination in Proportion to Roadmap Concept in Patients With HBV Associated-HCC

NCT01263002 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

33

Enrollment

INDUSTRY

Sponsor class

Conditions

Hepatitis B Associated Hepatocellular Carcinoma

Interventions

DRUG: clevudine, Adefovir

Sponsor

Bukwang Pharmaceutical